Cytomegalovirus oesophagitis following treatment with fludarabine for refractory lymphoplasmacytic lymphoma
- 1Milton Keynes General Hospital, Milton Keynes, UK
- 2Department of Haematology, Milton Keynes Hospital, Milton Keynes, UK
- Correspondence to Dr Nicola Pyatt, firstname.lastname@example.org
A 64-year-old man with a 2-week history of fatigue and fever presented to the medical admissions unit. He had a background of lymphoplasmacytic lymphoma and had recently completed a course of fludarabine-based chemotherapy. CT of the abdomen demonstrated an increase in spleen size and it was thought that his fevers were most likely due to disease recurrence or high-grade transformation. A bone marrow trephine was organised, which showed no evidence of lymphoma and positron emission tomography-CT demonstrated an area of increased avidity at the gastro-oesophageal junction. An oesophagogastroduodenoscopy was recommended, which revealed ulceration within the oesophagus and stomach. Biopsy of the lesions and immunohistochemistry confirmed a diagnosis of cytomegalovirus oesophagitis. He was treated with intravenous ganciclovir followed by oral valganciclovir for a total of 3 weeks. His fever resolved and he was discharged home approximately 8 weeks after he first presented.
Competing interests None.
Patient consent Obtained.